Kanishka Pothula
Direktor/Vorstandsmitglied bei TANGO THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Kanishka Pothula
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
University of California
166
| College/University | Other Consumer Services | 166 |
Georgetown University
157
| College/University | Other Consumer Services | 157 |
Public Company | Biotechnology | 14 | |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.
13
| Private Company | Investment Managers | 13 |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts.
3
| Subsidiary | Investment Managers | 3 |
BroadOak Capital Partners LLC
BroadOak Capital Partners LLC Investment ManagersFinance BroadOak Capital Partners LLC (BroadOak Capital Partners) is a private equity firm founded in 2006 by Bill Snider and Lars Hanan. The firm is headquartered in Maryland.
1
| Private Company | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kanishka Pothula
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Corporate Officer/Principal Analyst-Equity | |
University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity Analyst-Fixed Income Analyst-Equity | |
Stanford University | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Founder Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
UBS Securities LLC
UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Graduate Degree | |
Summit Partners LP
Summit Partners LP Investment ManagersFinance Summit Partners LP (Summit Partners) is a private equity firm founded in 1984 by Gregory Avis, Roe Stamps and Stephen Woodsum. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree | |
Texas A&M University | College/University | Undergraduate Degree Undergraduate Degree | |
Brighton Park Capital LLC
Brighton Park Capital LLC Investment ManagersFinance Brighton Park Capital LLC (Brighton Park capital) is a private equity firm founded in 2019 by Mark F. Dzialga. The firm is headquartered in Greenwich, Connecticut. | Investment Managers | Private Equity Investor Private Equity Investor | |
Columbia Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
NEON THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Indiana University | College/University | Undergraduate Degree Undergraduate Degree | |
RELAY THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Director/Board Member | |
NeuCures, Inc.
NeuCures, Inc. Medical/Nursing ServicesHealth Services NeuCures, Inc. engages in the provision of healthcare services. The company is headquartered in Marina del Rey, CA. | Medical/Nursing Services | Director/Board Member | |
University of Madras | College/University | Doctorate Degree | |
EP Dynamics, Inc. | Founder | ||
Epicardial Technologies, Inc.
Epicardial Technologies, Inc. Medical SpecialtiesHealth Technology Epicardial Technologies, Inc. manufactures electrophysiology devices to treat heart diseases. The private company is based in San Clemente, CA. | Medical Specialties | Director/Board Member | |
NeuTrace, Inc.
NeuTrace, Inc. Information Technology ServicesTechnology Services Part of Anumana, Inc., NeuTrace, Inc. is a medical technology company that develops AI applications for electrophysiology. The company is based in Longwood, FL. The company was founded by Kalyanam Shivkumar. NeuTrace was acquired by Anumana, Inc. on November 07, 2022. | Information Technology Services | Founder | |
Xerox Corp.
Xerox Corp. Computer PeripheralsElectronic Technology Xerox Corp. engages in the integration of paper and digital products. The firm offers home, office, office laser, multifunction and all in one printer, digital sheet-fed printing presses and scanner. The company was founded in 1906 and is headquartered in Norwalk, CT. | Computer Peripherals | Director/Board Member | |
BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Biotechnology | Corporate Officer/Principal | |
XENCOR, INC. | Biotechnology | Director/Board Member | |
Northwood Investors LLC
Northwood Investors LLC Investment ManagersFinance Northwood Investors LLC is a privately-held real estate investment advisor founded in 2006 by John Z. Kukral. The firm is headquartered in in New York City and Los Angeles, California. | Investment Managers | Private Equity Analyst | |
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
University of Michigan | College/University | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 48 |
Schweiz | 2 |
Luxemburg | 2 |
Indien | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 16 |
Finance | 14 |
Health Services | 3 |
Technology Services | 2 |
Operativ
Director/Board Member | 422 |
Independent Dir/Board Member | 185 |
Corporate Officer/Principal | 125 |
Undergraduate Degree | 85 |
Private Equity Investor | 53 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
William Hunter | 179 |
Robert Nolan | 32 |
Alexis Borisy | 25 |
Thomas Lips | 23 |
Alfred Scheidegger | 20 |
Thomas DeRosa | 20 |
Nagesh Mahanthappa | 19 |
Jakob Loven | 19 |
Aaron Davis | 19 |
Stephen Rodriguez | 19 |
Alexander Ery Wibowo | 19 |
Thilo Schroeder | 18 |
Ricky A. Pelletier | 18 |
Barbara Weber | 16 |
Thomas Cahill | 13 |
- Börse
- Insiders
- Kanishka Pothula
- Unternehmensverbindungen